Definitions of Urinary Tract Infection in Current Research: A Systematic Review

Abstract Defining urinary tract infection (UTI) is complex, as numerous clinical and diagnostic parameters are involved. In this systematic review, we aimed to gain insight into how UTI is defined across current studies. We included 47 studies, published between January 2019 and May 2022, investigating therapeutic or prophylactic interventions in adult patients with UTI. Signs and symptoms, pyuria, and a positive urine culture were required in 85%, 28%, and 55% of study definitions, respectively. Five studies (11%) required all 3 categories for the diagnosis of UTI. Thresholds for significant bacteriuria varied from 103 to 105 colony-forming units/mL. None of the 12 studies including acute cystitis and 2 of 12 (17%) defining acute pyelonephritis used identical definitions. Complicated UTI was defined by both host factors and systemic involvement in 9 of 14 (64%) studies. In conclusion, UTI definitions are heterogeneous across recent studies, highlighting the need for a consensus-based, research reference standard for UTI.

[1]  M. Numans,et al.  Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  R. Pickard,et al.  Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. , 2022, Health technology assessment.

[3]  P. Eckburg,et al.  Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection. , 2022, The New England journal of medicine.

[4]  Julia Sapozhnikov,et al.  Intravenous to Oral Antibiotics Versus Intravenous Antibiotics: A Step-Up or a Step-Down for Extended Spectrum Beta-Lactamase Producing Urinary Tract Infections Without Concomitant Bacteremia? , 2022, International journal of antimicrobial agents.

[5]  J. Rodríguez-Baño,et al.  Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections , 2022, JAMA network open.

[6]  Islam M. Ghazi,et al.  Is Cefoxitin a Carbapenem Sparing Agent in the Management of Urinary Tract Infections Caused by ESBL Producing Enterobacterales? , 2021, Hospital pharmacy.

[7]  S. REDDY B,et al.  ASSESSMENT OF EFFICACY AND SAFETY OF ORAL FOSFOMYCIN SINGLE DOSE IN UNCOMPLICATED URINARY TRACT INFECTION AT A TERTIARY CARE HOSPITAL IN SOUTH INDIA , 2021, Asian Journal of Pharmaceutical and Clinical Research.

[8]  S. Butler-Wu,et al.  Fosfomycin versus Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study , 2021, Open Forum Infectious Diseases.

[9]  C. Giske,et al.  The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden. , 2021, The Lancet. Infectious diseases.

[10]  A. Neisius,et al.  Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: a comparative single-centre study , 2021, International Urology and Nephrology.

[11]  J. R. Johnson,et al.  Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial. , 2021, JAMA.

[12]  P. Sand,et al.  Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial , 2021, International Urogynecology Journal.

[13]  T. Friede,et al.  Herbal treatment with Uva Ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[15]  H. Stammer,et al.  Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study , 2021, Archives of Gynecology and Obstetrics.

[16]  D. Guyonnet,et al.  High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial , 2021, BMC Urology.

[17]  N. Chen,et al.  A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection , 2020, Annals of medicine.

[18]  K. Cunha,et al.  Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment Outcomes , 2020, Research and reports in urology.

[19]  E. Pérez-Nadales,et al.  Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project) , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[20]  S. Kohno,et al.  The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study. , 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[21]  M. Arpi,et al.  Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus. , 2020, The Journal of antimicrobial chemotherapy.

[22]  Sara Abolghasemi,et al.  Levofloxacin versus ceftriaxone for treatment of acute pyelonephritis in Iranian adults. , 2020, Infectious disorders drug targets.

[23]  P. Popescu,et al.  Combination of cranberry extract and D-mannose - possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: Results of a pilot study. , 2020, Experimental and therapeutic medicine.

[24]  A. Barth,et al.  Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis) , 2020, Antimicrobial Agents and Chemotherapy.

[25]  A. Farsinezhad,et al.  The therapeutic effect of intravesical instillation of platelet rich plasma on recurrent bacterial cystitis in women: a randomized clinical trial. , 2019, Urology journal.

[26]  S. Cosgrove,et al.  Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms? , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Isaacs,et al.  Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis , 2019, Antimicrobial Agents and Chemotherapy.

[28]  Hong-Chiang Chang,et al.  The efficacy of pentosan polysulfate monotherapy for preventing recurrent urinary tract infections in women: A multicenter open-label randomized controlled trial. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[29]  R. Lepeule,et al.  Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[30]  Y. Trivedi,et al.  Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study , 2019, Expert review of anti-infective therapy.

[31]  J. Li,et al.  Colistin in the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical. , 2019, The Journal of infection.

[32]  A. Payasi,et al.  Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial , 2019, Open forum infectious diseases.

[33]  T. Benfield,et al.  Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial☆ , 2019, EClinicalMedicine.

[34]  E. Lukacz,et al.  Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. , 2019, Female pelvic medicine & reconstructive surgery.

[35]  C. van Nieuwkoop,et al.  Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria , 2019, The Journal of urology.

[36]  M. Bonten,et al.  Fosfomycin-Trometamol for Urinary Tract Infections in Kidney Transplant Recipients. , 2019, Transplantation.

[37]  G. Karsenty,et al.  A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis , 2019, Urologia Internationalis.

[38]  A. Edu,et al.  Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults , 2019, Urologia Internationalis.

[39]  S. Bai,et al.  Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study , 2019, Antimicrobial Agents and Chemotherapy.

[40]  L. Rice,et al.  Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  L. Miller,et al.  Once‐Daily Plazomicin for Complicated Urinary Tract Infections , 2019, The New England journal of medicine.

[42]  M. Yasuda,et al.  The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. , 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[43]  T. Tängdén,et al.  Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men , 2019, PloS one.

[44]  R. Parsons,et al.  The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study , 2019, PloS one.

[45]  S. Nimitvilai,et al.  Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial , 2019, Infection and drug resistance.

[46]  J. Pouliot,et al.  Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae , 2018, Hospital pharmacy.

[47]  A. Shahat,et al.  Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study , 2018, World Journal of Urology.

[48]  James R. Johnson Definitions of Complicated Urinary Tract Infection and Pyelonephritis. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  Betsy Foxman,et al.  Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. , 2014, Infectious disease clinics of North America.

[50]  A. Stapleton,et al.  Voided midstream urine culture and acute cystitis in premenopausal women. , 2013, The New England journal of medicine.

[51]  Philip Smith,et al.  Surveillance Definitions of Infections in Long-Term Care Facilities: Revisiting the McGeer Criteria , 2012, Infection Control & Hospital Epidemiology.

[52]  B. Trautner,et al.  Urinary Tract Infection , 2012, Annals of Internal Medicine.

[53]  K. Naber,et al.  Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. , 2011, International journal of antimicrobial agents.

[54]  G. Kaspers,et al.  Pyuria is absent during urinary tract infections in neutropenic patients , 2011, Pediatric blood & cancer.

[55]  Richard Colgan,et al.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  D. van den Broek,et al.  Benefits of the iQ200 automated urine microscopy analyser in routine urinalysis , 2008, Clinical chemistry and laboratory medicine.

[57]  M. André,et al.  Asymptomatic bacteriuria in the elderly: High prevalence and high turnover of strains , 2008, Scandinavian journal of infectious diseases.

[58]  Richard Colgan,et al.  Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  Michael L Wilson,et al.  Laboratory diagnosis of urinary tract infections in adult patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  Sanjay Saint,et al.  Does this woman have an acute uncomplicated urinary tract infection? , 2002, JAMA.

[61]  J. Schnelle,et al.  Accuracy of Rapid Urine Screening Tests Among Incontinent Nursing Home Residents with Asymptomatic Bacteriuria , 1995, Journal of the American Geriatrics Society.

[62]  K. Holmes,et al.  Diagnosis of coliform infection in acutely dysuric women. , 1982, The New England journal of medicine.

[63]  OUP accepted manuscript , 2021, Clinical Infectious Diseases.

[64]  Sami M. Aloush,et al.  Effectiveness of antibiotics versus ibuprofen in relieving symptoms of nosocomial urinary tract infection: A comparative study , 2019, Journal of the American Association of Nurse Practitioners.

[65]       ,et al.  NHG-Standaard Urineweginfecties , 2005 .